BI 1060469
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469
CompletedNCT01971502
Start: 2013-10-31End: 2014-02-28Updated: 2014-10-27
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
CompletedNCT02183545
Start: 2014-07-31End: 2014-10-31Updated: 2014-10-16
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
CompletedNCT02225626
Start: 2014-09-30End: 2014-12-31Updated: 2015-05-12